Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHGG and Sodium Hyaluronate for Chronic Constipation in Parkinson's Disease
NCT04569656Phase 2Completed
- Sponsor
- Fondazione San Raffaele Monte Tabor
- Start
- Feb 2016
- Primary completion
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes, Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of partially hydrolyzed guar gum, sodium hyaluronate in constipation, sponsored by Fondazione San Raffaele Monte Tabor. Started Feb 2016; status: completed.
02
Drugs
partially hydrolyzed guar gumsodium hyaluronate
03
Conditions
constipation
Beyond the preview
Go deeper on NCT04569656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04569656.